Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

599
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
599
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

743
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
743
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

567
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
567
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

4.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

5.0K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
5.0K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

1.6K
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward scalable species descriptions for dark taxa: the role of molecular data.

ZooKeys·2026
Same author

Integration and validation of complementary ex vivo assays for functional precision oncology.

NPJ precision oncology·2026
Same author

Performance and Safety of Smooth-Collar (Tissue-Level) Implants: A Case Report and Clinical Literature Review.

Cureus·2026
Same author

Impact of Cancer on Early Outcomes After Coronary Artery Bypass Grafting According to Cancer Stage-A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same author

Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach.

Scientific reports·2026
Same author

De Novo Chromosome-Level Assembly of the Endangered Pilocarpus Microphyllus Highlights Genomic Resources for Conservation and Sustainable Pilocarpine Extraction.

Genome biology and evolution·2026

Related Experiment Video

Updated: Apr 11, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

7.2K

HDAC8: a multifaceted target for therapeutic interventions.

Alokta Chakrabarti1, Ina Oehme2, Olaf Witt3

  • 1Institute of Pharmaceutical Sciences, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.

Trends in Pharmacological Sciences
|May 28, 2015
PubMed
Summary

Histone deacetylase 8 (HDAC8) is a promising drug target for cancer, intellectual disability, and infections. Developing selective HDAC8 inhibitors is key to minimizing side effects compared to broad-acting drugs.

Keywords:
Cornelia de Lange syndromeHDAC8X-ray crystallographycancerhistone deacetylasesschistosoma

More Related Videos

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

9.1K
High-Definition Transcranial Direct Current Stimulation During Sleep
09:23

High-Definition Transcranial Direct Current Stimulation During Sleep

Published on: December 5, 2025

424

Related Experiment Videos

Last Updated: Apr 11, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

7.2K
Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

9.1K
High-Definition Transcranial Direct Current Stimulation During Sleep
09:23

High-Definition Transcranial Direct Current Stimulation During Sleep

Published on: December 5, 2025

424

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Histone deacetylase 8 (HDAC8) is a Class I histone deacetylase.
  • HDAC8 plays a role in epigenetic regulation and deacetylates nonhistone proteins.
  • It is implicated in diseases such as cancer, X-linked intellectual disability, and parasitic infections.

Purpose of the Study:

  • To review HDAC8 as a potential therapeutic drug target.
  • To discuss the structural features of HDAC8 inhibitors.
  • To explore therapeutic interventions targeting HDAC8.

Main Methods:

  • Literature review of HDAC8 research.
  • Analysis of structural characteristics of HDAC8 inhibitors.
  • Examination of therapeutic applications and challenges.

Main Results:

  • HDAC8 is a critical epigenetic player in tumorigenesis.
  • HDAC8 is a novel target for combating parasitic and viral infections.
  • Selective HDAC8 inhibitors offer potential advantages over pan-HDAC inhibitors.

Conclusions:

  • HDAC8 represents a significant therapeutic target across diverse diseases.
  • Development of potent and selective HDAC8 inhibitors is crucial for effective treatment.
  • Targeting HDAC8 offers a promising strategy for novel therapeutic interventions.